A Controlled Trial of Renal Denervation for Resistant HypertensionDeepak L. Bhatt, George L. Bakris, David E. Kandzari et al.|New England Journal of Medicine|2014Cited by 2.2k
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trialDavid E. Kandzari, Denise Reedus, Jiro Aoki et al.|The Lancet|2018Cited by 775
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trialRaymond R. Townsend, Felix Mahfoud, David E. Kandzari et al.|The Lancet|2017Cited by 734
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trialMichael Böhm, Benjamin Blossom, Kazuomi Kario et al.|The Lancet|2020Cited by 586
Predictors of blood pressure response in the SYMPLICITY HTN-3 trialDavid E. Kandzari, George L. Bakris, Deepak L. Bhatt et al.|European Heart Journal|2014Cited by 540